Skip to main content
. 2018 Mar 6;10:29–35. doi: 10.1016/j.conctc.2018.02.005

Table 3.

Screening utilization of participants in a randomized control trial to increase colorectal cancer screening in medically-underserved populations.

Overall% A% B% p aORa aORb aORc
Ever had …
… FOBT 37.7 70.9 22.4 <.001 5.24 (3.21, 8.57) 5.51 (2.97, 10.21) 5.55 (3.36, 9.15)
… SIG 10.4 20.1 6.2 <.001 2.81 (1.39, 5.67) 3.04 (1.28, 7.21) 2.89 (1.43, 5.84)
… COL 50.6 67.8 42.6 <.001 1.74 (1.09, 2.77) 2.12 (1.18, 3.81) 1.86 (1.15, 3.01)
… ANY 65.2 87.8 54.4 <.001 2.91 (1.62, 5.21) 3.63 (1.80, 7.34) 3.28 (1.80, 6.00)



Up-To-Date …
… FOBT 9.3 21.2 3.7 <.001 5.44 (2.47, 11.99) 5.26 (2.03, 13.60) 5.53 (2.49, 12.30)
… SIG 5.4 11.5 2.4 <.001 4.20 (1.59, 11.11) 4.90 (1.53, 15.70) 4.65 (1.73, 12.50)
… COL 40.4 55.8 33.0 <.001 1.79 (1.14, 2.82) 2.02 (1.15, 3.52) 1.91 (1.20, 3.04)
… ANY 46.4 66.0 37.0 <.001 2.22 (1.40, 3.50) 2.62 (1.48, 4.63) 2.41 (1.50, 3.87)

cOR = crude odds ratio; aOR = adjusted odds ratio; FOBT = fecal occult blood test; SIG = sigmoidoscopy; COL = colonoscopy.

The reference category for all comparisons is Network B.

Bold text indicates a statistically significant difference with a p-value less than 0.05.

a

adjusted for age.

b

adjusted for age and race.

c

adjusted for age and insurance status.